Pyxis Oncology (PYXS) Cash from Operations (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Cash from Operations data on file, last reported at 10427000.0 in Q4 2025.

• Cash from Operations for Q4 2025 came in at 10427000.0, up 45.95% year-over-year; the trailing twelve-month figure through Dec 2025 was 63502000.0 (down 10.11% YoY), and the FY2025 annual result was 63502000.0, down 10.11% from the prior year.
• Cash from Operations rose to 10427000.0 in Q4 2025 per PYXS's latest filing, from 13277000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 2862000.0 in Q2 2021 and troughed at 27679000.0 in Q1 2022.
• A 5-year average of 15827200.0 and a median of 17325000.0 in 2022 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations plunged 928.51% in 2022, then soared 72.74% in 2024.
• A 5-year view of Cash from Operations shows it stood at 12169000.0 in 2021, then plunged by 42.88% to 17387000.0 in 2022, then advanced by 12.27% to 15254000.0 in 2023, then dropped by 26.46% to 19290000.0 in 2024, then surged by 45.95% to 10427000.0 in 2025.
• Business Quant data shows PYXS's Cash from Operations at 10427000.0 in Q4 2025, 13277000.0 in Q3 2025, and 17263000.0 in Q2 2025.